tirzepatide in mounjaro 2.5 mg / 0.5 ml Vial - Tirzepatide approved for weight loss

Clinical Trial Data: What the Evidence Actually Shows The STEP trials (Semaglutide Treatment Effect in People with Obesity) demonstrated dose-dependent weight loss over 68 weeks

Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, representing a novel class of incretin-based research compounds

Learn more: Geneva Med Spa Weight Loss Services Frequently Asked Questions What medications are offered

The timing of medication resumption after colonoscopy should also be discussed, typically allowing restart once normal oral intake is tolerated